New Directions in HCM Treatment

from Tales from the Heart · host Hypertrophic Cardiomyopathy Association / Lisa Salberg

Lisa Salberg and Dr. Marty Maron break down the rapidly changing landscape of HCM treatment, including the growing role of myosin inhibitors and what new clinical trial data could mean for patients. The conversation also explores beta blockers, shared care models, Centers of Excellence, and why personalized treatment matters more than ever. This conversation was recorded May 8, 2026.

Episode metadata supplied by the publisher feed · Published May 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

New Directions in HCM Treatment

0:00 56:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Tales from the Heart?

This episode is 56 minutes long.

When was this Tales from the Heart episode published?

This episode was published on May 11, 2026.

Can I download this Tales from the Heart episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!